Bo Ban
Impact in
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research
Papers in
-
- Growth Hormone and Insulin-like Growth Factors 20
-
- Gout, Hyperuricemia, Uric Acid 7
- Co-authors
- Yanjie Yang (8 shared papers)Xiaohui Qiu (7 shared papers)Zhengxue Qiao (7 shared papers)Xiuxian Yang (6 shared papers)Jiawei Zhou (3 shared papers)Mei Zhang (32 shared papers)Hui Pan (3 shared papers)Jing Chen (2 shared papers)
In The Last Decade
Bo Ban
70 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 121
- Rheumatology 124
- Biological Psychiatry 18
- Endocrinology, Diabetes and Metabolism 87
- Physiology 136
- Nephrology 37
Countries citing papers authored by Bo Ban
This map shows the geographic impact of Bo Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ban more than expected).
Fields of papers citing papers by Bo Ban
This network shows the impact of papers produced by Bo Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ban. The network helps show where Bo Ban may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Ban, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 182 | |
| 2 | 2018 | 109 | |
| 3 | 2016 | 91 | |
| 4 | 2018 | 74 | |
| 5 | 2015 | 70 | |
| 6 | 2017 | 61 | |
| 7 | 2014 | 55 | |
| 8 | 2022 | 35 | |
| 9 | 2022 | 28 | |
| 10 | 2021 | 24 | |
| 11 | 2020 | 23 | |
| 12 | 2019 | 21 | |
| 13 | 2017 | 21 | |
| 14 | 2016 | 20 | |
| 15 | 2020 | 20 | |
| 16 | 2021 | 20 | |
| 17 | 2014 | 18 | |
| 18 | 2021 | 14 | |
| 19 | 2024 | 14 | |
| 20 | 2022 | 13 |
About Bo Ban
Bo Ban is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology, having authored 74 papers that have together received 1.2k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (20 papers), Lipid metabolism and disorders (7 papers), Gout, Hyperuricemia, Uric Acid (7 papers), Metabolism, Diabetes, and Cancer (3 papers), Pregnancy and preeclampsia studies (3 papers), Systemic Lupus Erythematosus Research (3 papers), Birth, Development, and Health (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Rheumatology (124 citations), Biological Psychiatry (18 citations), Endocrinology, Diabetes and Metabolism (87 citations), Physiology (136 citations) and Nephrology (37 citations). Bo Ban has collaborated with scholars based in China, Hong Kong and Taiwan. Frequent co-authors include Yanjie Yang, Xiaohui Qiu, Zhengxue Qiao, Xiuxian Yang, Jiawei Zhou, Mei Zhang, Hui Pan, Jing Chen, Bo Bai and Bee Kang Tan. Their work appears in journals such as PLoS ONE, Scientific Reports, BioMed Research International, Diabetes Metabolic Syndrome and Obesity and Environmental Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.